| A Phase I, Open-label, Study of Pazopanib in Combination With Epirubicin or Doxorubicin for Advanced Solid Tumors (NCT00722293) | GlaxoSmithKline | 2008-07-08 |
| A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK1278863A in Healthy Subjects (NCT00750256) | GlaxoSmithKline | 2008-07-07 |
| PAXIL CR Bioequivalence Study (NCT00749359) | GlaxoSmithKline | 2008-07-07 |
| Study Evaluating The Safety And Tolerability Of Combination Therapy Inotuzumab Ozogamicin (CMC-544) And Rituximab (NCT00724971) | Pfizer | 2008-07-04 |
| PTC299 for Treatment of Advanced Cancer (NCT00704821) | PTC Therapeutics | 2008-07-03 |
| A Healthy Volunteer Study to Investigate the Relative Bioavailability of Two Forms of GSK598809 Capsules. (NCT00728897) | GlaxoSmithKline | 2008-07-02 |
| Dose Study in Healthy Japanese Males Investigating Safety, Pharmacokinetics and Pharmacodynamics of NNC126-0083 (NCT00722540) | Novo Nordisk A/S | 2008-07-01 |
| Cervical Multifidus Muscle Function (NCT00733837) | Logan College of Chiropractic | 2008-07-01 |
| CP-675,206 in Combination With Short Term Androgen Deprivation in Patients With Stage D0 Prostate Cancer (NCT00702923) | University of Wisconsin, Madison | 2008-07-01 |
| A Repeat Dose Study With GSK1018921 to Assess Safety, Tolerability, Pharmacokinetics, Pharmacodynamics in Healthy Volunteers and Patients With Schizophrenia and to Evaluate Its Effect on PK of Midazolam. (NCT00929370) | GlaxoSmithKline | 2008-07-01 |
| Study of the Poly (ADP-ribose) Polymerase-1 (PARP-1) Inhibitor BSI-201 in Patients With Newly Diagnosed Malignant Glioma (NCT00687765) | Sanofi | 2008-07-01 |
| A Phase 1b Trial in Patients With Renal Cell Cancer (NCT01258348) | Eli Lilly and Company | 2008-07-01 |
| A Combination Study With Ridaforolimus (MK8669) and Dalotuzumab (MK0646) in Patients With Advanced Cancer (8669-004) (NCT00730379) | Merck Sharp & Dohme LLC | 2008-07-01 |
| Pancreatic Islet Cell Transplantation After Kidney Transplantation - A Novel Approach to Immunosupression (NCT03047200) | Baylor Research Institute | 2008-07-01 |
| A Study to Evaluate Methodologies for Measuring Swelling of the Leg and Ankle (MK-0000-106)(COMPLETED) (NCT00789321) | Merck Sharp & Dohme LLC | 2008-07-01 |
| Safety and Tolerability Study With Single Ascending Doses of ORM-12741 (NCT00693316) | Orion Corporation, Orion Pharma | 2008-07-01 |
| Changes in Breast Cancer Biomarkers Using Synergistic Prostaglandin Inhibitors (NCT01425476) | Hartford Hospital | 2008-07-01 |
| A Phase I-Ib/II Study to Determine the Maximum Tolerated Dose (MTD) of AUY922 Alone and in Combination With Bortezomib, With or Without Dexamethasone, in Patients With Relapsed or Refractory Multiple Myeloma. (NCT00708292) | Novartis Pharmaceuticals | 2008-07-01 |
| A Study of ARRY-371797 in Patients With Rheumatoid Arthritis (NCT00729209) | Array Biopharma, now a wholly owned subsidiary of Pfizer | 2008-07-01 |
| Pancreatic Islet Cell Transplantation - A Novel Approach to Improve Islet Quality and Engraftment (NCT00530686) | Baylor Research Institute | 2008-07-01 |
| Phase 1 Pharmacokinetic Study Of CP-945598 In Patients With NASH (NCT00706537) | Pfizer | 2008-07-01 |
| Obatoclax and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma (NCT00719901) | National Cancer Institute (NCI) | 2008-07-01 |
| Multiple Respiration-Correlated Cone Beam Computed Tomography (CT) Scans to Reduce Target Positioning Errors in Radiotherapy Treatment of Thoracic Cancer (NCT00722605) | Memorial Sloan Kettering Cancer Center | 2008-07-01 |
| An Interaction Study of Ketoconazole/Verapamil Versus AZD1305 (NCT00707551) | AstraZeneca | 2008-07-01 |
| MK0752 in Treating Young Patients With Recurrent or Refractory CNS Cancer (NCT00572182) | Pediatric Brain Tumor Consortium | 2008-07-01 |
| Melphalan and Panobinostat (LBH589) for the Treatment of Patients With Recurrent Multiple Myeloma (NCT00743288) | Oncotherapeutics | 2008-07-01 |
| Cetuximab in Patients With Lung Adenocarcinoma Receiving Erlotinib That Have Developed "Acquired Resistance" to Erlotinib (NCT00716456) | Memorial Sloan Kettering Cancer Center | 2008-07-01 |
| Safety Study of the HemoModulator System for the Treatment of Patients With Human Immunodeficiency Virus (HIV) (NCT00858923) | Energex Systems, Inc. | 2008-07-01 |
| Safety Study of AZD5672 in Renally Impaired Subjects (NCT00715702) | AstraZeneca | 2008-07-01 |
| Safety Study of Anti-Asthma Agent BMEC-1217B (NCT00425971) | Medigreen Biotechnology Corp. | 2008-07-01 |
| CDP323 Biomarker Study (NCT00726648) | UCB Pharma | 2008-07-01 |
| A Study of the Safety, Pharmacokinetics, and Pharmacodynamics of MTRX1011A in Patients With Rheumatoid Arthritis (NCT00718588) | Genentech, Inc. | 2008-07-01 |
| Methotrexate, Glucarpidase, and Leucovorin in Treating Patients With Newly Diagnosed Primary Central Nervous System Lymphoma (NCT00727831) | University College, London | 2008-07-01 |
| Albinterferon Alfa 2b Single Dose in Japanese Chronic Hepatitis C Patients (NCT00724776) | Novartis | 2008-07-01 |
| Safety & Tolerability of the IRay System in Subjects With Exudative Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD) (NCT01217762) | Oraya Therapeutics, Inc. | 2008-07-01 |
| A Study In Patients With Advanced Solid Tumor (NCT00726752) | Pfizer | 2008-07-01 |
| Vaccine Therapy in Treating Women With Previously Treated Metastatic Breast Cancer (NCT00706615) | Jonsson Comprehensive Cancer Center | 2008-07-01 |
| Anaplerotic Therapy in Propionic Acidemia (NCT00645879) | Nicola Longo | 2008-07-01 |
| A Trial to Determine How Long Insulin and FDKP (the Molecule That Forms Technosphere Particles) Stays in the Lungs of Healthy Individuals After Inhalation of Technosphere® Insulin (TI) Powder Using Bronchoalveolar Lavage (BAL) (NCT00757367) | Mannkind Corporation | 2008-07-01 |
| TMC435350-TiDP16-C106: A Phase I Trial to Compare the Bioavailability and Plasma Pharmacokinetics After a Single Oral Dose of TMC435350 of 2 Different Solid Formulations Relative to a Powder Blend Capsule (NCT00752648) | Tibotec Pharmaceuticals, Ireland | 2008-07-01 |
| A Phase I/II Study to Assess the Safety and Efficacy of TKI258 for the Treatment of Refractory Advanced/Metastatic Renal Cell Cancer (NCT00715182) | Novartis Pharmaceuticals | 2008-07-01 |
| Helminth-induced Immunomodulation Therapy (HINT) in Relapsing-remitting Multiple Sclerosis (NCT00645749) | University of Wisconsin, Madison | 2008-07-01 |
| Standard Process 21 Day Purification Program Project (NCT00724217) | Logan College of Chiropractic | 2008-07-01 |
| Safety Study of FP-1039 To Treat Cancer (NCT00687505) | Five Prime Therapeutics, Inc. | 2008-07-01 |
| Mesenchymal Stem Cells in Multiple Sclerosis (MSCIMS) (NCT00395200) | University of Cambridge | 2008-07-01 |
| A Phase 1 Study of SB1518 for the Treatment of Advanced Lymphoid Malignancies (NCT00741871) | S*BIO | 2008-07-01 |
| Safety and Tolerability of Single and Multiple Doses of ISIS 353512 in Healthy Volunteers (NCT00734240) | Ionis Pharmaceuticals, Inc. | 2008-07-01 |
| A Phase 1b Study to Evaluate the Safety and PK of MP-376 in Chronic Obstructive Pulmonary Disease (COPD) Patients (NCT00752414) | Amgen | 2008-07-01 |
| Drug-Drug Interaction Study of Colchicine and Azithromycin (NCT00983294) | Mutual Pharmaceutical Company, Inc. | 2008-07-01 |
| Investigating Safety, Tolerability and Pharmakinetics When Giving Single and Fractionated Doses of AZD3241 to Healthy Volunteers (NCT00729443) | AstraZeneca | 2008-07-01 |
| An Assessment of the Safety of Varenicline in Methamphetamine-dependent Volunteers (NCT00713479) | University of California, Los Angeles | 2008-07-01 |
| A Phase I Study to Assess the Safety and Tolerability of Topical CRx-197 Formulations in Healthy Volunteers (NCT00721331) | Zalicus | 2008-07-01 |
| Effect Of Treatment With Oral Zolpidem On Polysomnography And Actigraphy Measures In Healthy Volunteers (NCT00716521) | Pfizer | 2008-07-01 |
| Single Dose Study of BMS-820836 (NCT00964912) | Bristol-Myers Squibb | 2008-07-01 |
| Trisenox, Ascorbic Acid and Bortezomib in Patients With Relapsed/Refractory Multiple Myeloma (NCT00590603) | Duke University | 2008-07-01 |
| Behavioral and Neuroimaging Changes After Cognitive Rehab in Traumatic Brain Injuries (TBI) and Mild Cognitive Impairment (MCI) (NCT00714571) | VA Office of Research and Development | 2008-07-01 |
| An Exploratory Study to Evaluate the Safety of Brimonidine Intravitreal Implant in Patients With Retinitis Pigmentosa (NCT00661479) | Allergan | 2008-07-01 |
| Effect of Continuous GHRP-3 Infusion at on GH-IGF-I System, Blood Pressure, Glucose, and Insulin Resistance (NCT00846872) | Tulane University Health Sciences Center | 2008-07-01 |
| Stem Cell Mobilization and VEGF Gene Transfer for Heart Failure (NCT00279539) | Losordo, Douglas, M.D. | 2008-07-01 |
| Clinical Trial to Evaluate Safety and Tolerability of OratecanTM in Patients With Advanced Solid Malignancies (NCT00979563) | Hanmi Pharmaceutical Company Limited | 2008-07-01 |
| Food Effects on the Relative Bioavailability of Different Dosages of Risedronate (NCT00717145) | Warner Chilcott | 2008-07-01 |
| Assessment of the Effect of Food on ABT-143 Bioavailability (NCT00719693) | AstraZeneca | 2008-07-01 |
| Study of the Safety and Tolerability of PCI-24781 in Patients With Lymphoma (NCT00724984) | Pharmacyclics LLC. | 2008-07-01 |
| An Investigation Of The Effects Of Food On The Absorption Of A Varenicline Controlled Release Formulation (NCT00731562) | Pfizer | 2008-07-01 |
| Study to Evaluate Bone Marrow Cells in the Treatment of Chronic Wounds (NCT02319720) | Dr. E.Badiavas | 2008-07-01 |
| Single-Dose Escalation Study of IDX184 in Healthy Volunteers (MK-2355-002) (NCT00730431) | Merck Sharp & Dohme LLC | 2008-07-01 |
| Safety and Dose Study of GRN163L and Velcade to Treat Patients With Refractory or Relapsed Myeloma (NCT00718601) | Geron Corporation | 2008-07-01 |
| Near-Infrared Fluorescent Sentinel Lymph Node Mapping for Breast Cancer (NCT00721370) | Beth Israel Deaconess Medical Center | 2008-07-01 |
| Study to Compare the Pharmacokinetics of Mycophenolate Mofetil Metabolites From Four Tablet Formulations in Healthy Participants (NCT02981290) | Hoffmann-La Roche | 2008-07-01 |
| Dose Finding and Safety Study of Deferoxamine in Patients With Brain Hemorrhage (NCT00598572) | Beth Israel Deaconess Medical Center | 2008-07-01 |
| Study to Assess OPB-31121 in Advanced Leukemias or Myelodysplastic Syndromes (NCT01029509) | M.D. Anderson Cancer Center | 2008-07-01 |
| Study of Individualized Wound Prevention Instruction to Prevent Venous Ulcer Development (NCT00727701) | US Department of Veterans Affairs | 2008-07-01 |
| Phase I/II Study of Z-208 in Advanced Hepatocellular Carcinoma (HCC) (NCT00731445) | Zeria Pharmaceutical | 2008-07-01 |
| Safety Study of Camptothecin-20-O-Propionate Hydrate (CZ48) (NCT02575638) | Cao Pharmaceuticals Inc. | 2008-07-01 |
| A Long-Term Study of the Effects of Orally Administered SAR302503 in Patients With Myelofibrosis (NCT00724334) | Bristol-Myers Squibb | 2008-07-01 |
| Pharmacokinetics and Safety of Single Subcutaneous Pasireotide (SOM230) in Subjects With Varying Degrees of Hepatic Function (NCT00698464) | Novartis Pharmaceuticals | 2008-07-01 |
| Inflammation After One Lung Ventilation (NCT02188407) | University Medical Centre Ljubljana | 2008-07-01 |
| Neoadjuvant Cetuximab in HNSCC Combined With Curative Surgery (NCT00714649) | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 2008-07-01 |
| A Study on the Tolerability and Early Efficacy of hLF1-11 in Patients With Proven Candidaemia (NCT00509834) | AM-Pharma | 2008-07-01 |
| Sirolimus to Treat Diabetic Macular Edema (NCT00711490) | National Eye Institute (NEI) | 2008-07-01 |
| Investigate the Effect of Neramexane Mesylate IR Tablet on Driving Fitness and Capability to Operate Machines in Healthy Volunteers (NCT00712283) | Merz Pharmaceuticals GmbH | 2008-07-01 |
| The Application of Cultured Cornea Stem Cells in Patients Suffering From Corneal Stem Cell Insufficiency (NCT01377311) | National Taiwan University Hospital | 2008-07-01 |
| Study of Controlled Release Formulations of CE-224,535 Against the Immediate Release Formulation in Normal Volunteers (NCT00782600) | Pfizer | 2008-07-01 |
| Phase I/II Trial of Radiation, Avastin and Tarceva for Pancreatic Adenocarcinoma (NCT00735306) | Duke University | 2008-07-01 |
| Safety, Tolerance, Pharmacokinetics and Activity of HE3286 in Patients With Rheumatoid Arthritis (NCT00712114) | Harbor Therapeutics | 2008-07-01 |
| A Phase I/II Study of HE3235 in Patients With Prostate Cancer (NCT00716794) | Harbor Therapeutics | 2008-07-01 |
| Binge Eating and Chromium Study (NCT00904306) | University of North Carolina, Chapel Hill | 2008-07-01 |
| A Study to Evaluate Safety and Tolerability After Oral Dosing of AZD1656 in Healthy Volunteers (NCT00726427) | AstraZeneca | 2008-07-01 |
| r-hGH Liquid Multidose Versus Freeze-dried Multidose Bioequivalence Trial (NCT01034735) | EMD Serono | 2008-07-01 |
| Use of Trastuzumab to Induce Increased ER Expression in ER-negative/Low, Her-2/Neu Positive Breast Cancer (NCT00726180) | University of Michigan Rogel Cancer Center | 2008-07-01 |
| Sunitinib, Cetuximab, and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck (NCT00906360) | National Cancer Institute (NCI) | 2008-07-01 |
| Efficacy of Inhaled Cannabis in Diabetic Painful Peripheral Neuropathy (NCT00781001) | Center for Medicinal Cannabis Research | 2008-07-01 |
| Determine the Effect of Multiple Doses of AZD7325, CYP Study (NCT00790114) | AstraZeneca | 2008-07-01 |
| Study to Assess the Effect of Dosing AZD6244 HydSulfate in the Presence and Absence of Food in Patients With Advanced Solid Malignancies (NCT00710515) | AstraZeneca | 2008-07-01 |
| Drug-Drug Interaction Between Colchicine and Ritonavir (NCT00983515) | Mutual Pharmaceutical Company, Inc. | 2008-07-01 |
| Aflibercept, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma Multiforme, Gliosarcoma, or Other Malignant Glioma (NCT00650923) | National Cancer Institute (NCI) | 2008-07-01 |
| A Dose Range Finding Study of Lenalidomide in Non-5q Chromosome Deletion in Low and Intermediate Risk Myelodysplastic Syndrome (MDS) Patients (NCT00699842) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2008-07-01 |
| TMC278-TiDP15-C150: Trial to Examine Safety, Tolerability and Plasma Pharmacokinetics of Multiple Doses of TMC278LA. (NCT00741741) | Tibotec Pharmaceuticals, Ireland | 2008-07-01 |
| Study of Busulfan for Refractory Central Nervous System (CNS) Tumors (NCT00836628) | Ann & Robert H Lurie Children's Hospital of Chicago | 2008-07-01 |
| Study to Determine the Maximum Tolerated Dose of BIBW 2992 (Afatinib) When Combined With Cisplatin/Paclitaxel or Cisplatin/5-FU in Patients With Advanced Solid Tumours (NCT00716417) | Boehringer Ingelheim | 2008-07-01 |